DHA 12-LOX-derived oxylipins regulate platelet activation and thrombus formation through a PKA-dependent signaling pathway.

作者: Adriana Yamaguchi , Livia Stanger , Cody J. Freedman , Melissa Standley , Timothy Hoang

DOI: 10.1111/JTH.15184

关键词: Docosahexaenoic acidPlateletPharmacologySignal transductionPolyunsaturated fatty acidChemistryImpaired platelet adhesionWhole bloodPlatelet activationProtein kinase A

摘要: Background The effects of docosahexaenoic acid (DHA) on cardiovascular disease are controversial and a mechanistic understanding how this omega-3 polyunsaturated fatty (ω-3 PUFA) regulates platelet reactivity the subsequent risk thrombotic event is warranted. In platelets, DHA oxidized by 12-lipoxygenase (12-LOX) producing lipids (oxylipins) 11-HDHA 14-HDHA. We hypothesized that 12-LOX DHA-oxylipins may be involved in beneficial observed dietary supplemental treatment with ω-3 PUFAs or itself. Objectives To determine DHA, 11-HDHA, 14-HDHA function thrombus formation, to elucidate mechanism which these regulate activation. Methods results attenuated collagen-induced human aggregation, but only oxylipins inhibited ⍺IIbβ3 activation decreased ⍺-granule secretion. Furthermore, whole blood its impaired adhesion accumulation collagen-coated surface. Interestingly, formation was diminished mice treated 14-HDHA, mouse following acute chronic suggesting under physiologic conditions, mediated through oxylipins. Finally, protective shown via protein kinase A. Conclusions This study provides first evidence inhibit activity formation. These findings support as therapeutic intervention atherothrombotic diseases.

参考文章(69)
M I Aveldaño, H Sprecher, Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets. Journal of Biological Chemistry. ,vol. 258, pp. 9339- 9343 ,(1983) , 10.1016/S0021-9258(17)44672-2
Martine Croset, Angelo Sala, Giancarlo Folco, Michel Lagarde, Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE. Biochemical Pharmacology. ,vol. 37, pp. 1275- 1280 ,(1988) , 10.1016/0006-2952(88)90782-4
A. SMOLENSKI, Novel roles of cAMP/cGMP-dependent signaling in platelets. Journal of Thrombosis and Haemostasis. ,vol. 10, pp. 167- 176 ,(2012) , 10.1111/J.1538-7836.2011.04576.X
Clemens von Schacky, The Effect of Dietary ω-3 Fatty Acids on Coronary Atherosclerosis Annals of Internal Medicine. ,vol. 130, pp. 554- 562 ,(1999) , 10.7326/0003-4819-130-7-199904060-00003
Marco Cattaneo, Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Seminars in Thrombosis and Hemostasis. ,vol. 35, pp. 158- 167 ,(2009) , 10.1055/S-0029-1220324
Massimiliano Pomponi, Luigi Janiri, Giuseppe La Torre, Enrico Di Stasio, Marco Di Nicola, Marianna Mazza, Giovanni Martinotti, Pietro Bria, Silvio Lippa, Renato Natili, Massimo F.L. Pomponi, Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA Journal of Psychiatric Research. ,vol. 47, pp. 337- 342 ,(2013) , 10.1016/J.JPSYCHIRES.2012.11.004
Sacha M Dopheide, Cindy L Yap, Shaun P Jackson, Dynamic aspects of platelet adhesion under flow. Clinical and Experimental Pharmacology and Physiology. ,vol. 28, pp. 355- 363 ,(2001) , 10.1046/J.1440-1681.2001.03468.X
P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel, M. Lagarde, M. Guichardant, Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation FEBS Letters. ,vol. 583, pp. 3478- 3484 ,(2009) , 10.1016/J.FEBSLET.2009.10.004
A. REHEMAN, P. GROSS, H. YANG, P. CHEN, D. ALLEN, V. LEYTIN, J. FREEDMAN, H. NI, Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 875- 883 ,(2005) , 10.1111/J.1538-7836.2005.01217.X